HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Advantage Alpha Capital Partners LP

Advantage Alpha Capital Partners LP lessened its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 13.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 72,013 shares of the company’s stock after selling 11,079 shares during the quarter. HealthEquity accounts for approximately 1.6% of Advantage Alpha Capital Partners LP’s holdings, making the stock its 13th largest holding. Advantage Alpha Capital Partners LP’s holdings in HealthEquity were worth $6,910,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the stock. Arcadia Investment Management Corp MI purchased a new stake in shares of HealthEquity in the fourth quarter worth about $26,000. Smartleaf Asset Management LLC raised its stake in shares of HealthEquity by 34.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after buying an additional 98 shares during the period. Proficio Capital Partners LLC acquired a new stake in shares of HealthEquity in the fourth quarter valued at about $39,000. UMB Bank n.a. lifted its stake in HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after buying an additional 164 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ boosted its holdings in HealthEquity by 1,934.8% in the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock worth $45,000 after buying an additional 445 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Stock Up 0.3 %

NASDAQ:HQY opened at $84.88 on Monday. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $115.59. The stock’s fifty day moving average is $104.90 and its two-hundred day moving average is $95.76. The stock has a market capitalization of $7.36 billion, a price-to-earnings ratio of 77.87, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on HQY. Raymond James raised their target price on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research report on Tuesday, February 25th. Mizuho began coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price target on the stock. Wells Fargo & Company upped their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research note on Wednesday, February 26th. Royal Bank of Canada upped their target price on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Tuesday, December 10th. Finally, JMP Securities boosted their price target on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research report on Tuesday, December 10th. One analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $112.92.

Insider Buying and Selling

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares of the company’s stock, valued at $8,704,992.51. The trade was a 6.85 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 2.20% of the stock is owned by corporate insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.